Search

Your search keyword '"Leufkens, H.G.M."' showing total 1,184 results

Search Constraints

Start Over You searched for: Author "Leufkens, H.G.M." Remove constraint Author: "Leufkens, H.G.M." Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,184 results on '"Leufkens, H.G.M."'

Search Results

12. A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature

13. The Application and Implications of Novel Deterministic Sensitivity Analysis Methods

14. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

21. Statin treatment and reduced risk of pneumonia in patients with diabetes

24. Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

25. Presenting the bill: a research about the costs and barriers in drug rediscovery

26. Predicting mortality in patients with heart failure: a pragmatic approach. (Cardiovascular Medicine)

28. Challenges in Advanced Therapy Medicinal Products Development: A survey amongst companies in Europe

29. Response to proposal for a novel cancer drug pricing model

30. Response to proposal for a novel cancer drug pricing model

31. Challenges in Advanced Therapy Medicinal Products Development: A survey amongst companies in Europe

32. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

33. Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons

34. Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study

35. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study

36. Risk of infections in patients with gout: a population-based cohort study

37. Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study

38. Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons

39. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?

40. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis

41. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

43. Asthma therapy during the first 8 years of life: a PIAMA cohort study

44. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands

45. Antibiotic prescribing for children in primary care and adherence to treatment guidelines

46. Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

47. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis

48. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?

49. Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

50. Antibiotic prescribing for children in primary care and adherence to treatment guidelines

Catalog

Books, media, physical & digital resources